Related Experiment Video
Updated: Mar 30, 2026
08:46
Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
10.3K
STAT3 Signaling in Polycystic Kidney Disease.
Thomas Weimbs1, Jeffrey J Talbot1
1Department of Molecular, Cellular, and Developmental Biology; and Neuroscience Research Institute, University of California, Santa Barbara, CA 93106-9610, U.S.A.
Drug Discovery Today. Disease Mechanisms
|November 3, 2015
Summary
STAT3 is aberrantly activated in autosomal-dominant polycystic kidney disease (ADPKD). Targeting STAT3 shows promise for treating ADPKD, a common kidney disease lacking approved therapies.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Autosomal-dominant polycystic kidney disease (ADPKD) is caused by mutations in polycystin-1 (PC1).
- ADPKD is a prevalent genetic disorder leading to kidney failure, with no approved treatments.
- STAT3 signaling is increasingly recognized in various cellular processes.
Purpose of the Study:
- To review the emerging role of Signal Transducer and Activator of Transcription 3 (STAT3) in ADPKD pathogenesis.
- To evaluate STAT3 as a potential therapeutic target for ADPKD.
Main Methods:
- Review of recent scientific literature and findings.
- Analysis of signaling pathways implicated in ADPKD, including STAT3 regulation by PC1.
- Examination of studies involving STAT3 inhibition in preclinical models of PKD.
Main Results:
- PC1 mutations are the primary cause of ADPKD.
- STAT3 is aberrantly activated in ADPKD kidneys from patients and mouse models.
- STAT3 inhibition has shown promising results in PKD mouse models.
- Multiple signaling pathways (e.g., EGF/EGFR, HGF/c-Met, Src) activate STAT3 and are linked to PKD.
Conclusions:
- STAT3 plays a significant, previously unrecognized role in the pathogenesis of ADPKD.
- Targeting STAT3 represents a promising therapeutic strategy for ADPKD treatment.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
6.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.3K
01:28Chronic Kidney Disease III: Interprofessional Care
621
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
621
01:20The JAK-STAT Signaling Pathway
13.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.9K
01:25Chronic Kidney Disease I: Introduction
1.1K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K
01:10Nephrons
8.8K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
8.8K
03:03mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K